ChondrosarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Chondrosarcoma
View Main Condition: Brain Tumor
Cleveland Clinic Main Campus
Gary Schwartz is a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 47 years. Dr. Schwartz is rated as an Elite provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, Hepato-Pancreato-Biliary Surgery, and Liver Embolization. Dr. Schwartz is board certified in American Board Of Internal Medicine, 1986.
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Elite provider by MediFind in the treatment of Chondrosarcoma. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery. Dr. Burgess is board certified in American Board Of Internal Medicine. Dr. Burgess is currently accepting new patients.
Duke Cancer Center
As an orthopaedic oncologist, I am passionate about providing the best diagnostic and therapeutic surgical care for patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. As the director of the Sarcoma program at the Duke Cancer Institute, my passion is building our team to provide the best clinical care and basic scientific, translational and clinical research to serve our patients. Dr. Brigman is rated as an Elite provider by MediFind in the treatment of Chondrosarcoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Chondrosarcoma, Bone Graft, and Hip Replacement. Dr. Brigman is board certified in American Board Of Orthopaedic Surgery, Orthopaedic Surgery.
Summary: To find the highest tolerable dose of IACS-6274 that can be given alone, in combination with bevacizumab and paclitaxel, or in combination with capivasertib to patients who have solid tumors. The safety and tolerability of the study drug(s) will also be studied.
Background: Cancers of the nasal cavity or skull base are rare. They often are not diagnosed until they are at an advanced stage, and they often spread to other parts of the body. These cancers may have mutations in a gene called IDH2. Researchers want to find out if a drug (enasidenib) that targets the IDH2 mutation can help people with these cancers.